Literature DB >> 15172995

Detection of an involvement of the human mismatch repair genes hMLH1 and hMSH2 in nucleotide excision repair is dependent on UVC fluence to cells.

David F Lee1, Regen Drouin, Photini Pitsikas, Andrew J Rainbow.   

Abstract

There is conflicting evidence for the role of the mismatch repair (MMR) genes hMLH1 and hMSH2 in the transcription-coupled repair (TCR) pathway of nucleotide excision repair. In the present work, we have examined the role of these MMR genes in nucleotide excision repair using two reporter gene assays. AdHCMVlacZ is a replication-deficient recombinant adenovirus that expresses the beta-galactosidase reporter gene under the control of the human cytomegalovirus immediate early promoter. We have reported previously a reduced host cell reactivation (HCR) for beta-galactosidase expression of UVC-irradiated AdHCMVlacZ in TCR-deficient Cockayne syndrome (CS) fibroblasts compared with normal fibroblasts, indicating that HCR depends, at least in part, on TCR. In addition, we have reported that UVC-enhanced expression of the undamaged reporter gene is induced at lower UVC fluences to cells and at higher levels after low UVC fluences in TCR-deficient compared with normal human fibroblasts, suggesting that persistent damage in active genes triggers increased activity from the human cytomegalovirus-driven reporter construct. We have examined HCR and UV-enhanced expression of the reporter gene in hMLH1-deficient HCT116 human colon adenocarcinoma cells and HCT116-chr3 cells (the MMR-proficient counterpart of HCT116) as well as hMSH2-deficient LoVo human colon adenocarcinoma cells and their hMSH2-proficient counterpart SW480 cells. We show a greater UV-enhanced expression of the undamaged reporter gene after low UVC exposure in HCT116 compared with HCT116-chr3 cells and in LoVo compared with SW480 cells. We show also a reduced HCR in HCT116 compared with HCT116-chr3 cells and in LoVo compared with SW480 cells. However, the reduction in HCR was less or absent when cells were pretreated with UVC. These results suggest that detection of an involvement of hMLH1 and hMSH2 in TCR is dependent on UVC (254 nm) fluence to cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172995     DOI: 10.1158/0008-5472.CAN-03-3193

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

Review 1.  Involvement of mismatch repair in transcription-coupled nucleotide excision repair.

Authors:  Katsutoshi Kobayashi; Peter Karran; Shinya Oda; Katsuhiko Yanaga
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

2.  A standardized protocol for the UV induction of Sulfolobus spindle-shaped virus 1.

Authors:  Salvatore Fusco; Martina Aulitto; Simonetta Bartolucci; Patrizia Contursi
Journal:  Extremophiles       Date:  2014-12-06       Impact factor: 2.395

3.  Human hHpr1/p84/Thoc1 regulates transcriptional elongation and physically links RNA polymerase II and RNA processing factors.

Authors:  Yanping Li; Xiaoling Wang; Xiaojing Zhang; David W Goodrich
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

4.  Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.

Authors:  Lawton J Stubbert; Jennifer M Smith; Bruce C McKay
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

5.  Excision of translesion synthesis errors orchestrates responses to helix-distorting DNA lesions.

Authors:  Anastasia Tsaalbi-Shtylik; Cristina Ferrás; Bea Pauw; Giel Hendriks; Piya Temviriyanukul; Leone Carlée; Fabienne Calléja; Sandrine van Hees; Jun-Ichi Akagi; Shigenori Iwai; Fumio Hanaoka; Jacob G Jansen; Niels de Wind
Journal:  J Cell Biol       Date:  2015-04-13       Impact factor: 10.539

6.  Role of high-dose exposure in transmission hot zones as a driver of SARS-CoV2 dynamics.

Authors:  Dominik Wodarz; Natalia L Komarova; Luis M Schang
Journal:  medRxiv       Date:  2020-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.